An antibody against the “don’t eat me” signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.
Author Krista Conger Published on March 5, 2019 March 5, 2019.
Read more
Anti-CD47 antibody trial in advanced cancers shows treatment appears safe, well-tolerated
Posted in biotech/medical